BRAF and thyroid gland papillary carcinoma: Combined statistical validation of HBME-1, galectin-3, and BRAF V600E co-expression in differentiating among papillary thyroid carcinoma, papillary thyroid hyperplasia, follicular adenoma, and follicular carcinoma.